TNF Antagonists Opened the Way to Personalized Medicine in Rheumatoid Arthritis

Overview of attention for article published in Molecular Medicine, December 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Exploring the causal relationship between 91 inflammatory cytokines and two subtypes of rheumatoid arthritis: a bidirectional two-sample Mendelian randomization study

Preprint in Research Square (February 2024)

Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach

Article in International Journal of Immunopathology and Pharmacology (January 2021)

The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation

Article in Clinical Pharmacology & Therapeutics (July 2017)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.